Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Protalix BioTherapeutics (PLX) Non Operating Income (2016 - 2025)

Historic Non Operating Income for Protalix BioTherapeutics (PLX) over the last 17 years, with Q3 2025 value amounting to $108000.0.

  • Protalix BioTherapeutics' Non Operating Income rose 17297.3% to $108000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $117000.0, marking a year-over-year increase of 11718.06%. This contributed to the annual value of $237000.0 for FY2024, which is 11251.32% up from last year.
  • Per Protalix BioTherapeutics' latest filing, its Non Operating Income stood at $108000.0 for Q3 2025, which was up 17297.3% from -$511000.0 recorded in Q2 2025.
  • In the past 5 years, Protalix BioTherapeutics' Non Operating Income ranged from a high of $413000.0 in Q1 2025 and a low of -$2.3 million during Q3 2021
  • In the last 5 years, Protalix BioTherapeutics' Non Operating Income had a median value of -$442000.0 in 2022 and averaged -$534210.5.
  • Per our database at Business Quant, Protalix BioTherapeutics' Non Operating Income tumbled by 50736.84% in 2023 and then skyrocketed by 23577.24% in 2025.
  • Protalix BioTherapeutics' Non Operating Income (Quarter) stood at -$910000.0 in 2021, then rose by 21.43% to -$715000.0 in 2022, then dropped by 13.43% to -$811000.0 in 2023, then surged by 113.19% to $107000.0 in 2024, then grew by 0.93% to $108000.0 in 2025.
  • Its Non Operating Income stands at $108000.0 for Q3 2025, versus -$511000.0 for Q2 2025 and $413000.0 for Q1 2025.